Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480440 · ClinicalTrials.gov registry record
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- 200
- Enrollment target
- 5
- Study locations
NCT01480440 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT01480440, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
Conditions Studied
Interventions
- DEVICE Trabecular Metal Reverse Shoulder System
Study Locations (5)
California
- University of California, San Francisco - San Francisco
Kentucky
- Norton Orthopaedic & Sports Medicine - Louisville
New Jersey
- The Rothman Institute - Egg Harbor
Pennsylvania
- The Rothman Institute - Philadelphia
Lancashire
- Royal Blackburn Hospital - Blackburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01480440
The ClinicalTrials.gov registry entry for NCT01480440 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Trabecular Metal Reverse Shoulder System is the first listed.
NCT01480440 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Kentucky, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01480440 about?
NCT01480440 is a clinical study titled "Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System". The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
What is the current status of trial NCT01480440?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2011-01. Estimated completion is 2026-12.
What conditions does trial NCT01480440 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Ununited Humeral Head Fracture.
What interventions are being tested in trial NCT01480440?
The interventions under investigation include: Trabecular Metal Reverse Shoulder System (DEVICE).
Who is sponsoring clinical trial NCT01480440?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01480440 being conducted?
This trial has 5 study locations across California, Kentucky, New Jersey, Pennsylvania, Lancashire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.